1.Date of the board of directors resolution or decision by the Company for record date: 2022/02/11
2.Whether to adopt shelf registration (Yes/No): No
3.Effective registration date approved by competent authority: 2022/01/18
4.Date of the board of directors resolution for additional issuance of shares: Not applicable
5.Issuance period: Not applicable
6.Number of shares issued: 30,000,000 common shares
7.The remaining shares after this issuance when adopting shelf registration: Not applicable
8.Par Value per share: 10 NTD
9.Total monetary value of the issuance: 300,000,000 NTD
10.Issue price: NTD 105 (Supplementary announcement)
11.Number of shares subscribed for by employees:
Pursuant to Article 267 of the Company Act, 15% (4,500,000 shares) of the total new shares are reserved for employees who are eligible.
12.Ratio of shares subscribed for by existing shareholders:
75% (22,500,000 shares) of the total new shares (112.90681794 shares per thousand shareholdings) will be subscribed by original shareholders based on the shareholding ratio stated on the register of shareholders on the reference date.
13.Method for public sale and no.of shares:
Pursuant to Article 28-1 of the Securities Exchange Act, 10% (3,000,000 shares) of the total new shares will be publicly underwritten.
14.Handling method for fractional shares and shares unsubscripted for by the deadline:
The original shareholder may apply to the stock transfer agent of the company within five days from the date for book closure to combine fractional shares into full shares. For fractional shares that fall short of full shares and shares that original shareholders and employees forfeit or insufficiently subscribe, the Chairman is authorized to contact designated persons for purchase at the issue price.
15.Rights and obligations of these newly issued shares:
Rights and obligations of the issued shares are the same as existing common shares.
16.Utilization of the funds from the current capital increase:
Support new drug research and development and enrich working capital.
17.Record date of cash capital increase and share subscription: 2022/2/26
18.Last date before book closure: 2022/2/21
19.Book closure starting date: 2022/2/22
20.Book closure ending date: 2022/2/26
21.Payment period:
(1)Payment period for existing shareholders and employees: 2022/3/4 ~ 2022/3/17
(2)Payment period for designated persons: 2022/3/18 ~ 2022/3/24
22.Date of the agreement with the banks to collect and deposit the proceeds: 2022/2/11 (Supplementary announcement)
23.Name of the institution designated to collect the proceeds: First Bank, Hsin-Hu Branch (Supplementary announcement)
24.Name of the bank designated to deposit the proceeds: E.Sun Bank, Nangang Branch (Supplementary announcement)
25.Any other matters that need to be specified: The capital increase through the issuance of new shares was approved by the Financial Supervisory Commission on January 18, 2022, approval letter No. 1100378381.